Minomycin: Potent Tetracycline Antibiotic for Systemic Infections
| Product dosage: 100mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $2.55 | $76.42 (0%) | 🛒 Add to cart |
| 60 | $2.38 | $152.85 $142.79 (7%) | 🛒 Add to cart |
| 90 | $2.34 | $229.27 $210.16 (8%) | 🛒 Add to cart |
| 120 | $2.30 | $305.69 $275.52 (10%) | 🛒 Add to cart |
| 180 | $2.27
Best per pill | $458.54 $408.26 (11%) | 🛒 Add to cart |
| Product dosage: 50mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $2.04 | $61.34 (0%) | 🛒 Add to cart |
| 60 | $1.88 | $122.68 $112.62 (8%) | 🛒 Add to cart |
| 90 | $1.81 | $184.02 $162.90 (11%) | 🛒 Add to cart |
| 120 | $1.78 | $245.36 $214.18 (13%) | 🛒 Add to cart |
| 180 | $1.75
Best per pill | $368.04 $314.74 (14%) | 🛒 Add to cart |
Synonyms | |||
Minomycin, known generically as minocycline, is a second-generation tetracycline-class antibiotic renowned for its broad-spectrum efficacy and enhanced absorption profile. It is specifically formulated to combat a wide array of bacterial infections, from respiratory and urinary tract infections to severe acne and certain sexually transmitted diseases. Its lipophilic nature allows for superior tissue penetration, making it a preferred choice for treating intracellular pathogens and inflammatory skin conditions. Clinicians value Minomycin for its reliability in both community and hospital settings, where targeted antibacterial action is critical. This product card provides a comprehensive overview tailored for healthcare professionals seeking detailed, evidence-based information.
Features
- Active ingredient: Minocycline hydrochloride
- Available formulations: 50 mg and 100 mg film-coated tablets
- Pharmacologic class: Tetracycline antibiotic
- Broad-spectrum activity against Gram-positive and Gram-negative bacteria, atypical pathogens, and some protozoa
- High oral bioavailability and lipophilicity for improved tissue penetration
- Convenient twice-daily dosing regimen to support patient adherence
Benefits
- Effectively eradicates a wide range of bacterial infections, reducing symptom duration and complication risks.
- Demonstrates excellent penetration into tissues, body fluids, and cells, targeting hard-to-reach pathogens.
- Supports inflammatory modulation in conditions like acne and rosacea, improving dermatologic outcomes.
- Offers flexible dosing aligned with infection severity and patient factors, allowing for personalized treatment plans.
- Helps minimize the development of resistance when used appropriately as part of antimicrobial stewardship.
Common use
Minomycin is indicated for the treatment of infections caused by susceptible strains of designated microorganisms. Common uses include respiratory tract infections such as bronchitis and pneumonia, urinary tract infections, skin and soft tissue infections including acne vulgaris, and sexually transmitted infections like chlamydia. It is also employed in the management of Rickettsial infections, Lyme disease, and as an adjunct in the treatment of inflammatory conditions where its immunomodulatory effects are beneficial.
Dosage and direction
The dosage of Minomycin should be individualized based on the type and severity of infection, patient weight, renal function, and clinical response. For most infections in adults, the usual dose is 200 mg initially, followed by 100 mg every 12 hours. Alternatively, 100 or 200 mg initially followed by 50 mg four times daily may be used. For severe infections, 100 mg every 12 hours is recommended. In renal impairment, dosage adjustment may be necessary. Tablets should be taken with a full glass of water to reduce the risk of esophageal irritation and ulceration, and preferably administered one hour before or two hours after meals, though it can be taken with food to minimize gastrointestinal upset if necessary. Treatment should be continued for at least 24–48 hours after symptoms and fever have subsided.
Precautions
Patients should be advised that Minomycin may cause dizziness, lightheadedness, or vertigo, which can impair the ability to drive or operate machinery. Use with caution in patients with hepatic or renal impairment; periodic renal and hepatic function tests are recommended during prolonged therapy. As with other antibiotics, Minomycin may result in overgrowth of nonsusceptible organisms, including fungi; if superinfection occurs, appropriate measures should be taken. It may cause photosensitivity; patients should avoid unnecessary sun exposure and use sunscreen. Tooth discoloration and enamel hypoplasia may occur if used during tooth development (last half of pregnancy, infancy, childhood up to age 8).
Contraindications
Minomycin is contraindicated in individuals with a known hypersensitivity to minocycline, other tetracyclines, or any component of the formulation. It should not be used in pregnancy due to the risk of fetal harm, including inhibition of bone growth and tooth discoloration. Use during lactation is not recommended as tetracyclines are excreted in breast milk and may affect bone and tooth development in the nursing infant. It is also contraindicated in children under 8 years of age for the same reasons.
Possible side effect
Common side effects include gastrointestinal disturbances such as nausea, vomiting, diarrhea, and abdominal pain. Dermatologic reactions like rash, photosensitivity, and pigmentation of skin and mucous membranes may occur. Neurologic effects including dizziness, lightheadedness, and vertigo are frequently reported. Less common but serious adverse reactions include pseudotumor cerebri, autoimmune syndromes, hepatitis, and blood dyscrasias. As with all antibiotics, Clostridium difficile-associated diarrhea ranging from mild to life-threatening colitis has been reported.
Drug interaction
Minomycin may interact with several medications: antacids containing aluminum, calcium, or magnesium, iron preparations, and bismuth subsalicylate can impair absorption—administer Minomycin 2 hours before or 3 hours after these agents. It may potentiate the effect of oral anticoagulants; monitor prothrombin time closely. Concurrent use with retinoids may increase the risk of pseudotumor cerebri. It may reduce the efficacy of oral contraceptives; advise alternative non-hormonal contraception. Barbiturates, carbamazepine, and phenytoin may decrease minocycline levels.
Missed dose
If a dose is missed, it should be taken as soon as remembered. However, if it is almost time for the next dose, the missed dose should be skipped and the regular dosing schedule resumed. Doubling the dose to make up for a missed one is not recommended, as it may increase the risk of side effects.
Overdose
Overdose may lead to nausea, vomiting, and diarrhea. No specific antidote is available; management should be supportive and symptomatic. Gastric lavage may be considered if ingestion was recent. Hemodialysis is not effective in removing minocycline due to high protein binding. In cases of severe toxicity, monitor renal, hepatic, and hematopoietic function, and institute appropriate therapy.
Storage
Store at room temperature between 15–30°C (59–86°F) in a tightly closed container, protected from light and moisture. Keep out of reach of children and pets. Do not use after the expiration date printed on the packaging.
Disclaimer
This information is intended for healthcare professionals and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of a qualified healthcare provider with any questions regarding a medical condition or medication. The prescribing physician should be consulted for specific recommendations tailored to the individual patient.
Reviews
Clinical studies and post-marketing surveillance have consistently demonstrated the efficacy and tolerability of Minomycin. In a meta-analysis of dermatologic use, it showed significant improvement in inflammatory acne lesions with a favorable safety profile. For respiratory infections, it has been effective against atypical pathogens like Mycoplasma pneumoniae. Some reports note dizziness as a common but manageable side effect. Overall, it remains a valuable option in the antibiotic arsenal, particularly for its tissue penetration and broad-spectrum coverage.